Precision for Medicine Named Top 20 Bioinformatics Solution Provider
We are proud to be recognized as one of the Top 20 Bioinformatics Solution Providers by respected technology trends magazine CIO Applications. (more…)
Schafer Discusses Challenges of Gene Therapy Reimbursement
Jeremy Schafer, director of Precision’s Payer Access Solutions, details the challenges facing gene therapy reimbursement and offers potential solutions. (more…)
Schafer Looks Ahead in the Latest Issue of Market Access Spotlight
Jeremy Schafer, director of Precision’s Payer Access Solutions, shares his thoughts on drug pricing, M&A activity, 340B changes, and other things top-of-mind for 2018. (more…)
February Issue of Precision’s All Access Available Now
The February issue of All Access, Precision’s free newsletter featuring articles by former payers written specifically for market access leaders, is now available. (more…)
Precision Value & Health Acquires Leading Market Access Consultancy Insight Strategy Advisors
ADDITION OF NEW YORK-BASED FIRM COMPLEMENTS AND STRATEGICALLY EXPANDS PRECISION’S EXISTING GLOBAL MARKET ACCESS EXPERTISE AND CAPABILITIES
New York, NY – Tuesday, January 30, 2018 – Precision Value & Health today announced it is acquiring Insight Strategy Advisors (ISA), a New York-based leading market access consultancy supporting value demonstration, pricing, reimbursement, and distribution for biopharmaceutical companies. ISA will become part of Precision Xtract, the global market access consultancy within Precision Value & Health.
Schafer Discusses Improving Cancer Drug Accessibility with Managed Healthcare Executive
Jeremy Schafer, SVP, Director of Precision’s Payer Access Solutions, offers advice to healthcare executives on helping patients get access to crucial new cancer drugs. (more…)
Kohler and Guennel Discuss Biomarker Drug Development & New FDA Data Requirements in Regulatory Focus
Precision for Medicine’s Jared Kohler and Tobias Guennel highlight the challenges for researchers pursuing biomarkers and specialty lab data that meet new FDA regulatory standards. (more…)
Jeremy Schafer Comments in Specialty Pharmacy News on Overcoming Costs for Gene Therapy
Jeremy Schafer, director of Precision’s Payer Access Solutions, offers insights into combating the risk and exposures of gene therapy. (more…)
Jeremy Schafer Address Payer Concerns on Dermira’s Acne Treatment in BioPharma
Jeremy Schafer, director of Precision’s Payer Access Solutions, weighs in on the concern of payer coverage for Dermira’s acne topical treatment. (more…)
Digital Biomarkers Becoming Integral to Precision Medicine
In a new commentary for Pharmaceutical Market Europe, Precision for Value’s Austin Speier, VP, Emerging Technology, examines the promise and advantages of integrating digital biomarkers into precision medicine. (more…)